107 related articles for article (PubMed ID: 15226621)
1. [Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)].
Kawakami Y; Nagino K; Shinkai K; Sobue S; Abe M; Ishiko J
Nihon Yakurigaku Zasshi; 2004 Jul; 124(1):41-51. PubMed ID: 15226621
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers.
Sobue S; Tan K; Layton G; Eve M; Sanderson JB
Br J Clin Pharmacol; 2004 Jul; 58(1):20-5. PubMed ID: 15206988
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
Aoyama T; Hirata K; Hirata R; Yamazaki H; Yamamoto Y; Hayashi H; Matsumoto Y
J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
[TBL] [Abstract][Full Text] [Related]
4. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Haug-Pihale G
Br J Clin Pharmacol; 2005 Feb; 59(2):160-6. PubMed ID: 15676037
[TBL] [Abstract][Full Text] [Related]
5. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
Sobue S; Tan K; Layton G; Leclerc V; Weil A
Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fluconazole and fosfluconazole after intraperitoneal administration to peritoneal dialysis rats.
Aoyama T; Ogata K; Shimizu M; Hatta S; Masuhara K; Shima Y; Kimura K; Matsumoto Y
Drug Metab Pharmacokinet; 2005 Dec; 20(6):485-90. PubMed ID: 16415533
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of Fosfluconazole after single intravenous bolus injection in healthy male Japanese volunteers.
Sobue S; Sekiguchi K; Shimatani K; Tan K
J Clin Pharmacol; 2004 Mar; 44(3):284-92. PubMed ID: 14973307
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers.
Sobue S; Tan K; Shaw L; Layton G; Hust R
Eur J Clin Pharmacol; 2004 Jun; 60(4):247-53. PubMed ID: 15103438
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants.
Tanzawa A; Saito J; Shoji K; Kojo Y; Funaki T; Maruyama H; Isayama T; Ito Y; Nakamura H; Yamatani A
Microbiol Spectr; 2022 Apr; 10(2):e0195221. PubMed ID: 35266811
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of D0870 against murine infections and its mechanism of action.
Yamada H; Tsuda T; Watanabe T; Kusakabe S; Mochizuki H
Chemotherapy; 1998; 44(2):112-20. PubMed ID: 9551242
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of fluconazole on deep-seated fungal infections].
Ikemoto H; Watanabe K; Mori T; Taniuchi A; Akahonai Y; Mikuni C; Yoshida K; Kasai M; Kawamura K; Yoshida T
Jpn J Antibiot; 1989 Jan; 42(1):63-116. PubMed ID: 2540369
[TBL] [Abstract][Full Text] [Related]
12. Case of cryptococcal choroiditis in adult with T-cell leukemia/lymphoma.
Yamada W; Yamada H; Murata K; Kosugi H; Asano Y; Mochizuki K; Ishida K
J Infect Chemother; 2019 Jan; 25(1):59-64. PubMed ID: 30057340
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
Debruyne D
Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole.
Med Lett Drugs Ther; 1990 May; 32(818):50-2. PubMed ID: 2185400
[No Abstract] [Full Text] [Related]
15. A clinical study of fluconazole for the treatment of deep mycoses.
Ikemoto H
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):239S-247S. PubMed ID: 2556241
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Ikeda F
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
[TBL] [Abstract][Full Text] [Related]
18. [A multiple center clinical trial on fluconazole for deep-seated fungal infections].
Liang D; Xu N; Zhang H
Zhonghua Nei Ke Za Zhi; 1995 Dec; 34(12):823-6. PubMed ID: 8731861
[TBL] [Abstract][Full Text] [Related]
19. [Experience of fluconazole in pediatric patients].
Arai S; Iguchi K; Kamiya H; Sakurai M
Jpn J Antibiot; 1989 Jan; 42(1):165-70. PubMed ID: 2540362
[TBL] [Abstract][Full Text] [Related]
20. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
